Table 6. The analysis of heterogeneity and publication bias.
Group | SNP | Comparison | Heterogeneity | Model | Begg's test | Egger's test | |||
---|---|---|---|---|---|---|---|---|---|
I2 | Pheterogeneity | z | PBegg | t | PEgger | ||||
SSC | rs1800629 | A vs G | 77.5% | <0.001 | Random | 0.49 | 0.621 | 0.07 | 0.942 |
AA vs GG | 30.0% | 0.137 | Fixed | 1.20 | 0.228 | 1.67 | 0.120 | ||
GA vs GG | 66.3% | <0.001 | Random | 0.00 | 1.000 | −0.42 | 0.683 | ||
GA+AA vs GG | 71.4% | <0.001 | Random | −0.05 | 1.000 | −0.12 | 0.903 | ||
AA vs GG+GA | 23.2% | 0.203 | Fixed | 1.20 | 0.228 | 1.75 | 0.105 | ||
carrier A vs G | 64.0 % | <0.001 | Random | 0.00 | 1.000 | −0.17 | 0.864 | ||
SSC | rs361525 | A vs G | 66.2% | 0.019 | Random | 0.73 | 0.462 | 0.05 | 0.962 |
GA vs GG | 67.7% | 0.015 | Random | 0.73 | 0.462 | 0.05 | 0.962 | ||
GA+AA vs GG | 59.8% | 0.029 | Random | 0.38 | 0.707 | 0.09 | 0.930 | ||
carrier A vs G | 63.2% | 0.028 | Random | 0.73 | 0.462 | −0.03 | 0.978 | ||
skin cancer | rs1800629 | A vs G | 46.1% | 0.084 | Fixed | 0.30 | 0.764 | −0.68 | 0.528 |
AA vs GG | 38.6% | 0.148 | Fixed | 0.38 | 0.707 | 0.33 | 0.756 | ||
GA vs GG | 45.4% | 0.089 | Fixed | 0.30 | 0.764 | −1.36 | 0.233 | ||
GA+AA vs GG | 46.6% | 0.081 | Fixed | 0.60 | 0.548 | −1.04 | 0.347 | ||
AA vs GG+GA | 38.1% | 0.152 | Fixed | 0.38 | 0.707 | 0.49 | 0.650 | ||
carrier A vs G | 7.4% | 0.372 | Fixed | 0.30 | 0.764 | −0.95 | 0.387 |
SCC: squamous cell carcinoma; SNP: single nucleotide polymorphisms.